Neuropsychiatric lupus erythematosus: A 10-year prospective study on the value of diagnostic tests

The American Journal of Medicine

Volumn 99, Issue 2, 1995, Pages 153-163

  West, Sterling G ^a   Emlen, Woodruff ^b   Wener, Mark H ^c   Kotzin, Brian L ^b,d  

^a FITZSIMONS ARMY MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; IMMUNOGLOBULIN; PHOSPHOLIPID ANTIBODY;

ARTICLE; CEREBROSPINAL FLUID EXAMINATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; LUPUS ERYTHEMATOSUS; MAJOR CLINICAL STUDY; NEUROPSYCHIATRY; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SERODIAGNOSIS;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTICARDIOLIPIN; AUTOANTIBODIES; BRAIN; CASE-CONTROL STUDIES; CEREBROSPINAL FLUID PROTEINS; FEMALE; HUMAN; LUPUS COAGULATION INHIBITOR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGE; NEURONS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RIBOSOMAL PROTEINS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0029125306     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)80135-1     Document Type: Article

References (44)

1. Neuropsychiatric lupus
2. The diversity of neurologic events in systemic lupus erythematosus
3. Central nervous system involvement in SLE. Diagnostic profile and clinical features
4. The 1982 revised criteria for the classification of systemic lupus erythematosus
5. Central nervous system lupus erythematosus. The need for classification
6. CNS lupus
7. The lupus activity criteria count (LACC)
8. Differentiation of nuclear antibodies giving speckled staining patterns in immunofluorescence
9. A millipore filter assay for antibodies to native DNA in sera of patients with systemic lupus erythematosus
10. A new double-stranded DNA specific ELISA for the detection of DNA antibodies
11. Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus
12. Report of the working party on acquired inhibitors of coagulation: studies on the lupus anticoagulant
13. Laboratory diagnosis of lupus inhibitors: a comparison of tissue thromboplastin inhibition procedure with a new platelet neutralization procedure
14. The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants
15. Antiphospholipid antibodies in predicting adverse pregnancy outcome. A prospective study
16. Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin test
17. Principles of albumin and IgG analysis in neurological disorders. I. Establishment of reference values
18. Principles of albumin and IgG analyses in neurological disorders. II. Relation of the concentration of the protein in serum and cerebrospinal fluid
19. Agarose gel electrophoresis
20. Changes in size of normal lateral ventricles during aging determined by computerized tomography
21. The neurological manifestations of systemic lupus erythematosus
22. Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955–1977
23. Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombotic thrombocytopenia purpura
24. Neuropathologic findings in multi-infarct dementia associated with anticardiolipin antibody
25. Neurocytotoxic antibodies in serum of patients with systemic lupus erythematosus
26. Association of IgG anti=brain antibodies with central nervous system dysfunction in systemic lupus erythematosus
27. Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus
28. Antineuronal antibodies in neuropsychiatric systemic lupus erythematosus
29. Intrathecal IgG synthesis and blood-brain barrier impairment in patients with systemic lupus erythematosus and central nervous system dysfunction
30. Cerebrospinal fluid immune complexes in systemic lupus erythematosus involving the central nervous system
31. Cerebrospinal fluid immunoglobulin abnormalities in systemic lupus erythematosus
32. A serial study of changes in intrathecal immunoglobulin synthesis in a patient with central nervous system lupus erythematosus
33. Antiribosomal P protein antibodies in systemic lupus erythematosus. A reappraisal
34. Autoantibodies to the ribosomal P proteins react with a plasma membrane-related target on human cells
35. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders
36. The lupus anticoagulant and anticardiolipin antibodies
37. Aortic insufficiency and mitral regurgitation in patients with systemic lupus erythematosus and the antiphospholipid syndrome
38. Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies
39. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus
40. Cerebral ischemic events associated with endocarditis, renal vascular disease, and lupus anticoagulant
41. Magnetic resonance imaging of the brain in neuropsychiatric systemic lupus erythematosus
42. Magnetic resonance imaging versus computed tomographic scanning in neuropsychiatric systemic lupus erythematosus